Evidence map›Paper›PMID 39900763›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Enhancing Robust and Stable Feature Selection Through the Integration of Ranking Methods and Wrapper Techniques in Genetic Data Classification.

Maryam Yassi, Mohammad Hossein Moattar, Matthew Parry, Aniruddha Chatterjee

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maryam YassiDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
Mohammad Hossein MoattarDepartment of Computer Engineering, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Matthew ParryDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
Aniruddha ChatterjeeDepartment of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. aniruddha.chatterjee@otago.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-dimensional data expands the spatial dimension, leading to increased computational complexity and reduced generalization performance. Microarray data classification, such as diagnosing diseases like cancer, involves complex dimensions due to their genetic and biological information. To address this issue, dimension reduction is essential for these data sets. The main goal of this chapter is to provide a method for dimension reduction and classification of genetic data sets. The proposed approach comprises multiple stages. Initially, various feature ranking methods are combined to improve the robustness and stability of the feature selection process. A hybrid ranking method, which incorporates gene interactions, is integrated with a wrapper method. Subsequently, a support vector machine (SVM) is employed for classification. To address class imbalance in the training data, a solution is implemented before feeding the data into the SVM classifier. The experimental outcomes of the proposed approach, tested on five microarray databases, indicate robust feature selection with a metric ranging from 0.70 to 0.88. Additionally, the classification accuracy falls within the range of 91-96%.

Indexed as

Computational BiologyGene Expression ProfilingOligonucleotide Array Sequence AnalysisAlgorithmsDatabases, GeneticHumansSoftwareSupport Vector MachineClass imbalanceDimension reductionfiLter methodMicroarray classificationSupport vector machineWrapper method

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.